(Q40661125)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Alejandro Sánchez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

María Tobío

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Libia González

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Angels Fabra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmaceutical Sciences

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

221-229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Therapeutic potential for orally administered type 1 interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Controlled release of interleukin-2 from biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Pharmacokinetic studies with recombinant cytokines. Scientific issues and practical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

New strategies for the microencapsulation of tetanus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Stealth PLA-PEG nanoparticles as protein carriers for nasal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

Factors affecting the in vitro release of recombinant human interferon-gamma (rhIFN-gamma) from PLGA microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2803%2900019-8

7 January 2021

10.1016/S0928-0987(03)00019-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12659933%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference